Published in Neuroimage on January 14, 2012
A review of feature reduction techniques in neuroimaging. Neuroinformatics (2014) 1.16
The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex. Biol Psychiatry (2014) 0.97
Automated, high accuracy classification of Parkinsonian disorders: a pattern recognition approach. PLoS One (2013) 0.95
Multivariate decoding of brain images using ordinal regression. Neuroimage (2013) 0.91
Improving response inhibition in Parkinson's disease with atomoxetine. Biol Psychiatry (2014) 0.91
Bayesian multi-task learning for decoding multi-subject neuroimaging data. Neuroimage (2014) 0.89
Annual research review: Current limitations and future directions in MRI studies of child- and adult-onset developmental psychopathologies. J Child Psychol Psychiatry (2014) 0.86
Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe. Clin Drug Investig (2016) 0.85
Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension (2014) 0.82
Effect of predictive cuing on response inhibition in children with heavy prenatal alcohol exposure. Alcohol Clin Exp Res (2012) 0.82
Acute neuropharmacological effects of atomoxetine on inhibitory control in ADHD children: a fNIRS study. Neuroimage Clin (2014) 0.81
The Effects of Methylphenidate on Resting-State Functional Connectivity of the Basal Nucleus of Meynert, Locus Coeruleus, and Ventral Tegmental Area in Healthy Adults. Front Hum Neurosci (2016) 0.78
Modulatory effects of ketamine, risperidone and lamotrigine on resting brain perfusion in healthy human subjects. Psychopharmacology (Berl) (2015) 0.78
The role of machine learning in neuroimaging for drug discovery and development. Psychopharmacology (Berl) (2015) 0.78
Multivariate decoding of cerebral blood flow measures in a clinical model of on-going postsurgical pain. Hum Brain Mapp (2014) 0.77
Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Int J Neuropsychopharmacol (2015) 0.77
Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit/hyperactivity disorder: a pilot study. Psychiatry Res (2012) 0.77
Phenomenologically distinct psychotomimetic effects of ketamine are associated with cerebral blood flow changes in functionally relevant cerebral foci: a continuous arterial spin labelling study. Psychopharmacology (Berl) (2015) 0.76
Estimating multivariate similarity between neuroimaging datasets with sparse canonical correlation analysis: an application to perfusion imaging. Front Neurosci (2015) 0.76
The search for imaging biomarkers in psychiatric disorders. Nat Med (2016) 0.76
ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder. Ther Innov Regul Sci (2015) 0.76
The effects of methylphenidate on cerebral responses to conflict anticipation and unsigned prediction error in a stop-signal task. J Psychopharmacol (2016) 0.75
The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder. Neuroimage Clin (2016) 0.75
Fast robust automated brain extraction. Hum Brain Mapp (2002) 41.79
Perfusion imaging. Magn Reson Med (1992) 7.40
Sparse multinomial logistic regression: fast algorithms and generalization bounds. IEEE Trans Pattern Anal Mach Intell (2005) 7.38
Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A (1992) 6.83
Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med (2008) 5.23
Modeling the hemodynamic response to brain activation. Neuroimage (2004) 5.15
Classifying brain states and determining the discriminating activation patterns: Support Vector Machine on functional MRI data. Neuroimage (2005) 4.83
What is the correct value for the brain--blood partition coefficient for water? J Cereb Blood Flow Metab (1985) 4.81
Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature (2004) 4.79
A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med (1998) 4.38
Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab (1996) 4.30
Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med (2004) 4.25
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology (2002) 3.79
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry (2008) 3.34
Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci U S A (1998) 2.91
Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol (2006) 2.60
Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci (1979) 2.51
Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry (1998) 2.50
Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics (2001) 2.48
Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci (2000) 2.47
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci (2002) 2.46
Dopaminergic regulation of cerebral cortical microcirculation. Nat Neurosci (1998) 2.35
Efficiency of inversion pulses for background suppressed arterial spin labeling. Magn Reson Med (2005) 2.27
The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J Comp Neurol (1975) 2.08
Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol (1988) 1.99
Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry (2008) 1.89
Sparse estimation automatically selects voxels relevant for the decoding of fMRI activity patterns. Neuroimage (2008) 1.83
Interpreting oxygenation-based neuroimaging signals: the importance and the challenge of understanding brain oxygen metabolism. Front Neuroenergetics (2010) 1.77
Brain reading using full brain support vector machines for object recognition: there is no "face" identification area. Neural Comput (2008) 1.74
Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease. Neuroimage (2008) 1.72
Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse (1994) 1.68
Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Brain Res Rev (2004) 1.63
Sparse logistic regression for whole-brain classification of fMRI data. Neuroimage (2010) 1.61
Clinical pharmacokinetics of atomoxetine. Clin Pharmacokinet (2005) 1.55
Immunocytochemical localization of the dopamine transporter in human brain. J Comp Neurol (1999) 1.55
Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry (1998) 1.53
The primate thalamus is a key target for brain dopamine. J Neurosci (2005) 1.52
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol (2004) 1.49
Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo. Biol Psychiatry (2010) 1.44
Pharmacokinetics of methylphenidate in man, rat and monkey. J Pharmacol Exp Ther (1983) 1.36
Prediction and interpretation of distributed neural activity with sparse models. Neuroimage (2008) 1.35
Anti-hyperactivity medication: methylphenidate and amphetamine. Mol Psychiatry (1998) 1.35
Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm Gen Sect (1993) 1.32
Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorder. Neuropsychopharmacology (2011) 1.32
Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci (1993) 1.31
Methylphenidate has differential effects on blood oxygenation level-dependent signal related to cognitive subprocesses of reversal learning. J Neurosci (2008) 1.31
Distribution of the dopamine innervation in the macaque and human thalamus. Neuroimage (2006) 1.26
Central noradrenergic regulation of cerebral blood flow and vascular permeability. Proc Natl Acad Sci U S A (1975) 1.24
[3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J Pharmacol Exp Ther (1992) 1.23
Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry (1997) 1.21
A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. J Pharmacol Exp Ther (1982) 1.18
Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice. J Neurochem (2010) 1.17
Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study. Adv Ther (2006) 1.14
Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity. Biol Psychiatry (2004) 1.13
Abnormal regional brain function in Parkinson's disease: truth or fiction? Neuroimage (2008) 1.12
Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers. Neuropsychopharmacology (2011) 1.10
Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis. Behav Brain Funct (2005) 1.05
Tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in the primate cerebellum. Evidence for a lobular- and laminar-specific dopamine innervation. Neuropsychopharmacology (2000) 1.01
Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Neuropsychopharmacology (2006) 1.00
Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2. Eur Neuropsychopharmacol (2005) 0.99
Neural correlates of error monitoring modulated by atomoxetine in healthy volunteers. Biol Psychiatry (2010) 0.98
Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD. J Natl Med Assoc (2005) 0.95
Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis. Brain Res (1990) 0.93
Methylphenidate-induced activation of the anterior cingulate but not the striatum: a [15O]H2O PET study in healthy volunteers. Hum Brain Mapp (2007) 0.93
Specific in vitro binding of (S,S)-[3H]MeNER to norepinephrine transporters. Synapse (2005) 0.90
Distribution of tracer levels of cocaine in the human brain as assessed with averaged [11C]cocaine images. Synapse (1999) 0.86
Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study. Life Sci (1992) 0.86
Noradrenergic systems in human cerebellum. Brain Res (1989) 0.77
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med (2008) 5.23
Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry (2003) 4.84
Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry (2004) 3.85
MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology (2004) 3.59
The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry (2005) 3.16
A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry (2005) 3.15
Amplitude-modulated continuous arterial spin-labeling 3.0-T perfusion MR imaging with a single coil: feasibility study. Radiology (2005) 2.69
PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature (2007) 2.63
Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry (2011) 2.47
Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla. Magn Reson Med (2002) 2.43
Efficiency of inversion pulses for background suppressed arterial spin labeling. Magn Reson Med (2005) 2.27
Arterial transit time imaging with flow encoding arterial spin tagging (FEAST). Magn Reson Med (2003) 2.25
A link between FTO, ghrelin, and impaired brain food-cue responsivity. J Clin Invest (2013) 2.23
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study. Lancet Neurol (2012) 2.22
Amygdala, hippocampal and corpus callosum size following severe early institutional deprivation: the English and Romanian Adoptees study pilot. J Child Psychol Psychiatry (2009) 2.08
Age effects on diffusion tensor magnetic resonance imaging tractography measures of frontal cortex connections in schizophrenia. Hum Brain Mapp (2006) 2.00
Mapping infant brain myelination with magnetic resonance imaging. J Neurosci (2011) 1.97
Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry (2008) 1.96
Grey and white matter distribution in very preterm adolescents mediates neurodevelopmental outcome. Brain (2007) 1.91
Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage (2004) 1.86
Salience network integrity predicts default mode network function after traumatic brain injury. Proc Natl Acad Sci U S A (2012) 1.86
Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease. NMR Biomed (2010) 1.85
Medial prefrontal cortex activity associated with symptom provocation in eating disorders. Am J Psychiatry (2004) 1.84
Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage (2002) 1.82
Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care (2007) 1.77
Overlapping structural and functional brain changes in patients with long-term exposure to fibromyalgia pain. Arthritis Rheum (2013) 1.76
Measuring fMRI reliability with the intra-class correlation coefficient. Neuroimage (2008) 1.75
A double dissociation of ventromedial prefrontal cortical responses to sad and happy stimuli in depressed and healthy individuals. Biol Psychiatry (2005) 1.73
Novel risk markers and long-term outcomes of delirium: the successful aging after elective surgery (SAGES) study design and methods. J Am Med Dir Assoc (2012) 1.73
Effects of dietary glycemic index on brain regions related to reward and craving in men. Am J Clin Nutr (2013) 1.73
Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling. J Magn Reson Imaging (2007) 1.72
Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain. Pain (2009) 1.72
A diffusion tensor imaging study of fasciculi in schizophrenia. Am J Psychiatry (2007) 1.71
Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry (2008) 1.70
Differential neural responses to overt and covert presentations of facial expressions of fear and disgust. Neuroimage (2004) 1.69
Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies. Schizophr Res (2010) 1.64
A functional MRI study of happy and sad affective states induced by classical music. Hum Brain Mapp (2007) 1.62
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology (2009) 1.62
Neural systems underlying British Sign Language and audio-visual English processing in native users. Brain (2002) 1.60
Cognitive effects of nicotine in humans: an fMRI study. Neuroimage (2003) 1.59
Defining the role of cholecystokinin in the lipid-induced human brain activation matrix. Gastroenterology (2010) 1.58
Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation. Biol Psychiatry (2012) 1.56
A preferential increase in the extrastriate response to signals of danger. Neuroimage (2003) 1.54
Age-related differences in brain activation during emotional face processing. Neurobiol Aging (2002) 1.54
Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care (2006) 1.52
Acute sleep deprivation enhances the brain's response to hedonic food stimuli: an fMRI study. J Clin Endocrinol Metab (2012) 1.51
Correction of head movement on PET studies: comparison of methods. J Nucl Med (2006) 1.50
Neural specialization for letter recognition. J Cogn Neurosci (2002) 1.46
Arterial spin labeling MR imaging for characterisation of renal masses in patients with impaired renal function: initial experience. Eur Radiol (2011) 1.44
Amide proton transfer imaging with improved robustness to magnetic field inhomogeneity and magnetization transfer asymmetry using saturation with frequency alternating RF irradiation. Magn Reson Med (2011) 1.43
Task instructions modulate neural responses to fearful facial expressions. Biol Psychiatry (2003) 1.43
Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model? Radiology (2009) 1.42
DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls. Neuropsychopharmacology (2010) 1.40
Effects of transcranial direct current stimulation (tDCS) on human regional cerebral blood flow. Neuroimage (2011) 1.40
Mapping IQ and gray matter density in healthy young people. Neuroimage (2004) 1.39
Can spherical deconvolution provide more information than fiber orientations? Hindrance modulated orientational anisotropy, a true-tract specific index to characterize white matter diffusion. Hum Brain Mapp (2012) 1.37
Cognitive enhancement by drugs in health and disease. Trends Cogn Sci (2010) 1.35
Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. Brain (2011) 1.34
Dorsolateral prefrontal cortex activity predicts responsiveness to cognitive-behavioral therapy in schizophrenia. Biol Psychiatry (2009) 1.33
Differential neural responses to food images in women with bulimia versus anorexia nervosa. PLoS One (2011) 1.33
Recovery and chronicity in anorexia nervosa: brain activity associated with differential outcomes. Biol Psychiatry (2003) 1.33
Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression. PLoS One (2011) 1.32
Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Hum Brain Mapp (2009) 1.32
Early specialization for voice and emotion processing in the infant brain. Curr Biol (2011) 1.31
The dopaminergic basis of human behaviors: A review of molecular imaging studies. Neurosci Biobehav Rev (2009) 1.30
The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging (2011) 1.30
A multislice gradient echo pulse sequence for CEST imaging. Magn Reson Med (2010) 1.29
Neural correlates of executive function and working memory in the 'at-risk mental state'. Br J Psychiatry (2009) 1.29
Reduced resolution transit delay prescan for quantitative continuous arterial spin labeling perfusion imaging. Magn Reson Med (2011) 1.29
Changes in cortical grey matter density associated with long-standing retinal visual field defects. Brain (2009) 1.27
Procedural learning in schizophrenia: a functional magnetic resonance imaging investigation. Schizophr Res (2002) 1.27
Patients with fibromyalgia display less functional connectivity in the brain's pain inhibitory network. Mol Pain (2012) 1.26
Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging. Neuroradiology (2009) 1.26
Cerebral blood flow in posterior cortical nodes of the default mode network decreases with task engagement but remains higher than in most brain regions. Cereb Cortex (2010) 1.26
Myelin water imaging reflects clinical variability in multiple sclerosis. Neuroimage (2011) 1.24
Decomposing the neural correlates of antisaccade eye movements using event-related FMRI. Cereb Cortex (2007) 1.22
Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma. Clin Cancer Res (2008) 1.20
Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res (2003) 1.20
Aging, brain disease, and reserve: implications for delirium. Am J Geriatr Psychiatry (2010) 1.20
Susceptibility contrast and arterial spin labeled perfusion MRI in cerebrovascular disease. J Neuroimaging (2003) 1.20
Misattribution of speech and impaired connectivity in patients with auditory verbal hallucinations. Hum Brain Mapp (2007) 1.20
Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans. J Cereb Blood Flow Metab (2009) 1.19
The effect of negative emotional context on neural and behavioural responses to oesophageal stimulation. Brain (2003) 1.19
Assessment of functional development in normal infant brain using arterial spin labeled perfusion MRI. Neuroimage (2007) 1.19
Functional MRI in ADHD: a systematic literature review. Expert Rev Neurother (2007) 1.16
A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics. Int J Neuropsychopharmacol (2006) 1.15
Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement. Eur Radiol (2006) 1.15
Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia. Neuropsychopharmacology (2006) 1.14
Maximizing clinical research participation in vulnerable older persons: identification of barriers and motivators. J Am Geriatr Soc (2008) 1.13
Power calculations for multicenter imaging studies controlled by the false discovery rate. Hum Brain Mapp (2010) 1.13
Hyporesponsive reward anticipation in the basal ganglia following severe institutional deprivation early in life. J Cogn Neurosci (2010) 1.13
Human attachment security is mediated by the amygdala: evidence from combined fMRI and psychophysiological measures. Hum Brain Mapp (2006) 1.11
A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biol Psychiatry (2007) 1.11